| 製品番号 |
製品名 |
製品効果
|
純度 |
Rare Diseases
|
| HY-148905 |
p-Aminophenylmercuric acetate |
Activator |
98.32% |
Unkown |
| HY-110397 |
KP-457 |
Inhibitor |
98.88% |
Unkown |
| HY-113952 |
Actinonin |
|
98.37% |
Unkown |
| HY-P4931 |
Mca-KPLGL-Dap(Dnp)-AR-NH2 |
|
99.30% |
Unkown |
| HY-N1454 |
Apigenin-7-glucuronide |
Inhibitor |
99.74% |
Unkown |
| HY-128133 |
MMP-8 inhibitor-1 |
Inhibitor |
99.70% |
Unkown |
| HY-N1463 |
Luteolin 7-O-glucuronide |
Inhibitor |
99.98% |
Unkown |
| HY-162038 |
RXP03 |
Inhibitor |
98.82% |
Unkown |
| HY-107639 |
UK-370106 |
Inhibitor |
≥99.0% |
Unkown |
| HY-110397G |
KP-457 (GMP) |
Inhibitor |
/ |
Unkown |
| HY-19485 |
XL-784 |
Inhibitor |
98.25% |
Unkown |
| HY-114091 |
PF-00356231 hydrochloride |
Inhibitor |
99.52% |
Unkown |
| HY-147745 |
MMP2-IN-2 |
Inhibitor |
98.80% |
Unkown |
| HY-110116 |
SD-2590 hydrochloride |
Inhibitor |
99.4% |
Unkown |
| HY-147746 |
MMP2-IN-3 |
Inhibitor |
99.64% |
Unkown |
| HY-RS08555 |
Mmp8 Mouse Pre-designed siRNA Set A |
|
/ |
Unkown |
| HY-113621B |
Ageladine A dihydrochloride |
Inhibitor |
/ |
Unkown |
| HY-114091A |
PF-00356231 |
Inhibitor |
/ |
Unkown |
| HY-114396 |
BR351 |
Inhibitor |
/ |
Unkown |
| HY-137793 |
Pro-Leu-Gly-NHOH hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-168605 |
DH-18 |
|
/ |
Unkown |
| HY-175275 |
10-Butyl Ether Minocycline |
Inhibitor |
/ |
Unkown |
| HY-180765 |
Colchicine-O-CO-Enyl(Me)-Enyl-Enyl(Me)-Enyl-1,3,3-trimethylcyclohex-1-ene |
Activator |
/ |
Unkown |
| HY-182795 |
Colchicine derivative-1 |
|
/ |
Unkown |
| HY-P10972 |
GIP (22-51) human |
|
/ |
Unkown |
| HY-P2682 |
MMP-8/MMP-26 Fluorogenic substrate |
|
/ |
Unkown |
| HY-P3699 |
TNO003 |
Substrate |
/ |
Unkown |
| HY-RS08554 |
MMP8 Human Pre-designed siRNA Set A |
|
/ |
Unkown |
| HY-RS08556 |
Mmp8 Rat Pre-designed siRNA Set A |
|
/ |
Unkown |
| HY-35513 |
3-Aminobenzene-1,2-diol |
Inhibitor |
98.0% |
Unkown |
| HY-43586 |
BR351 precursor |
Inhibitor |
/ |
Unkown |
| HY-P3699A |
TNO003 TFA |
Substrate |
/ |
Unkown |